The Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC) is a cohesive and extensive group of Neuro-Ophthalmologists,
other doctors, coordinators, biostatisticians, clinical trial experts and reading centers, who have developed a structured organization to
perform prospective clinical research with the support of the National Eye Institute of the NIH, other funding agencies, and industry.
Click here to read our mission statement
- NORDIC is currently conducting one major study, Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). IIH, also called pseudotumor cerebri, is a disorder of elevated intracranial pressure of unknown case. Its incidence is 22.5 new cases each year per 100,000 overweight women of childbearing age; its incidence is rising in parallel with the obesity epidemic. It affects about 100,000 Americans. Learn More
- Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients. Learn More